The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians of the recall of Losartan potassium tablet by its manufacturers.
A statement by Prof. Moji Adeyeye, NAFDAC’s Director General, on Thursday revealed that the tablet, manufactured by Hetero Labs Limited, Unit – I (API manufacturer), was recalled after detection of some dangerous impurity.
She said that the tablet was used for the treatment of high blood pressure and congestive heart failure.
“NAFDAC has been notified about the recall of Losartan potassium tablet 25 mg, 50 mg and 100 mg by Camber Pharmaceuticals…” Read more
